Alexander Nowak
Stock Analyst at Craig-Hallum
(2.72)
# 1,875
Out of 5,150 analysts
46
Total ratings
45.95%
Success rate
7.12%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $112.18 | -3.73% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $8.49 | +159.13% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $203.03 | -22.67% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $8.47 | +100.71% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $21.19 | +168.99% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $19.06 | -21.30% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $7.77 | +2.96% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.44 | +1,150.00% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $23.41 | +113.58% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $9.40 | +1,602.13% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $103.50 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.79 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.20 | +400.00% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $57.85 | +90.15% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $6.87 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $1.44 | +20,733.33% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.60 | +191.67% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $112.18
Upside: -3.73%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $8.49
Upside: +159.13%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $203.03
Upside: -22.67%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $8.47
Upside: +100.71%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $21.19
Upside: +168.99%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $19.06
Upside: -21.30%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $7.77
Upside: +2.96%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.44
Upside: +1,150.00%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $23.41
Upside: +113.58%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $9.40
Upside: +1,602.13%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $103.50
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.79
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.20
Upside: +400.00%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $57.85
Upside: +90.15%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $6.87
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $1.44
Upside: +20,733.33%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.60
Upside: +191.67%